Igf2, the neurotrophic peptide insulin-like growth factor-2, has neuroprotective function (Beletskiy et al., 2021) and was expectedly downregulated in TgF344-AD rats at 12 months. This evidence concerns the gene IGF2 and Alzheimer disease.